Caplacizumab April 12, 2017 Caplacizumab Trade Name Orphan Indication Thrombotic thrombocytopenic purpura USA Market Approval USA USA Designation Date 2009-04-14 00:00:00 Sponsor Ablynx NV;Technologiepark 21, B-9052;Zwijnaarde
